首页> 外文期刊>British Journal of Cancer >Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems
【24h】

Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems

机译:检测和实时定量异种移植系统中人类细胞的灵敏PCR方法

获取原文
           

摘要

The sensitive detection of human cells in immunodeficient rodents is a prerequisite for the monitoring of micrometastasis of solid tumours, dissemination of leukaemic cells, or engraftment of haematological cells. We developed a universally applicable polymerase chain reaction method for the detection of a human-specific 850-bp fragment of the α-satellite DNA on human chromosome 17. The method allows the detection of one human cell in 106 murine cells and could be established as both, a conventional DNA polymerase chain reaction-assay for routine screening, and a quantitative real-time polymerase chain reaction-assay using TaqMan-methodology. It was applied to the following xenotransplantation systems in SCID and NOD/SCID mice: (1) In a limiting dilution assay, cells of the MDA-MB 435 breast carcinoma were injected into the mammary fat pad of NOD/SCID mice. It could be shown that 10 cells mouse?1 were sufficient to induce a positive polymerase chain reaction signal in liver and lung tissue 30 days after transplantation as an indicator for micrometastasis. At this time a palpable tumour was not yet detectable in the mammary fat pad region. (2) Cells of a newly established human acute lymphatic leukaemia were administered intraperitoneally to SCID mice. These cells apparently disseminated and were detectable as early as day 50 in the peripheral blood of living mice, while the leukaemia manifestation was delayed by day 140. (3) In a transplantation experiment using mature human lymphocytes we wanted to standardise conditions for a successful survival of these cells in NOD/SCID mice. It was established that at least 5×107 cells given intravenously were necessary and that the mice had to be conditioned by 2 Gy body irradiation to get positive polymerase chain reaction bands in several organs. (4) Engraftment studies with blood stem cells originating from cytapheresis samples of tumour patients or from cord blood were undertaken in NOD/SCID mice in order to define conditions of successful engraftment and to use this model for further optimisation strategies. The polymerase chain reaction method presented allowed a reliable prediction of positive engraftment and agreed well with the results of immunohistochemical or FACS analysis. All together, the polymerase chain reaction method developed allows a sensitive and reliable detection of low numbers of human cells in immunodeficient hosts. In combination with real-time (TaqMan) technique it allows an exact quantification of human cells. As this method can be performed with accessible material of living animals, follow up studies for the monitoring of therapeutic interventions are possible in which the survival time of mice as evaluation criteria can be omitted.
机译:免疫缺陷啮齿动物中人体细胞的灵敏检测是监测实体瘤微转移,白血病细胞扩散或血液细胞移植的前提。我们开发了一种普遍适用的聚合酶链反应方法,用于检测人类17号染色​​体上人类特异性850 bp的α-卫星DNA片段。该方法可以检测106个鼠细胞中的一个人类细胞,并且可以确定为常规筛查的常规DNA聚合酶链反应分析,以及使用TaqMan方法的实时定量聚合酶链反应分析。将其应用于SCID和NOD / SCID小鼠的以下异种移植系统:(1)在有限稀释试验中,将MDA-MB 435乳腺癌细胞注射到NOD / SCID小鼠的乳腺脂肪垫中。可以证明,移植后30天,有10个细胞的小鼠γ1足以在肝和肺组织中诱导阳性聚合酶链反应信号,作为微转移的指标。此时,在乳腺脂肪垫区域仍未检测到明显的肿瘤。 (2)向SCID小鼠腹膜内施用新建立的人急性淋巴白血病的细胞。这些细胞显然在活小鼠的外周血中扩散并最早可在第50天被发现,而白血病的表现则延迟了140天。(3)在使用成熟人类淋巴细胞的移植实验中,我们希望标准化成功存活的条件这些细胞在NOD / SCID小鼠中。已经确定至少需要静脉注射5×107个细胞,并且必须通过2 Gy体辐射对小鼠进行调节,以在多个器官中获得阳性聚合酶链反应带。 (4)在NOD / SCID小鼠中进行了来源于肿瘤患者的细胞分离术样品或脐带血的血干细胞的移植研究,以确定成功移植的条件并将该模型用于进一步的优化策略。提出的聚合酶链反应方法可以可靠地预测阳性植入,并与免疫组织化学或FACS分析的结果很好地吻合。总之,开发的聚合酶链反应方法可对免疫缺陷宿主中的少量人类细胞进行灵敏可靠的检测。结合实时(TaqMan)技术,可以对人类细胞进行精确定量。由于该方法可以用活体动物的可触及材料进行,因此有可能进行监测治疗干预措施的后续研究,其中可以忽略小鼠的存活时间作为评估标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号